Aprea Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $118 | $0 | $205 | $354 |
Gross Profit | 112 | 157 | 200 | 349 |
EBITDA | -3,387 | -4,085 | -3,220 | -4,091 |
EBIT | -4,091 | -3,226 | -4,097 | |
Net Income | -3,238 | -3,932 | -2,894 | -3,783 |
Net Change In Cash | 118 | 0 | 205 | 354 |
Free Cash Flow | -3,130 | -3,631 | -3,510 | -2,468 |
Cash | 16,532 | 19,275 | 22,849 | 26,249 |
Basic Shares | 6,083 | 5,993 | 5,954 | 5,939 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,502 | $583 | $0 | $0 |
Gross Profit | 1,480 | 576 | -186 | -271 |
EBITDA | -12,936 | -14,279 | -112,475 | -36,855 |
EBIT | -12,958 | -14,286 | -112,662 | -37,127 |
Net Income | -12,958 | -14,286 | -224,875 | -36,536 |
Net Change In Cash | 1,502 | 583 | 0 | 0 |
Free Cash Flow | -13,572 | -12,270 | -25,011 | -37,686 |
Cash | 22,849 | 21,606 | 28,786 | 53,076 |
Basic Shares | 5,509 | 3,617 | 82 | 1,064 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.53 |
2025-03-31 | -$0.65 |
2024-12-31 | -$0.49 |
2024-09-30 | -$0.64 |
